| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $6.56B | $5.96B | $5.64B |
| YoY Revenue Growth % | +10.2% | +5.6% | — |
| Gross Profit | — | — | — |
| Gross Margin % | — | — | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $1.19B | $1.28B | $444.0M |
| Operating Margin % | 18.1% | 21.4% | 7.9% |
| Net Income (GAAP) | $1.01B | $1.08B | $376.3M |
| EBITDA (Normalized) | $1.43B | $1.49B | $647.2M |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | -$40.9M | $1.84B | $1.26B |
| Capital Expenditures (CapEx) | $295.4M | $268.1M | $254.0M |
| Free Cash Flow (FCF) | -$336.3M | $1.58B | $1.00B |
| FCF Margin % | -5.1% | 26.5% | 17.7% |
| Return on Invested Capital (ROIC %) | 5.2% | 6.3% | 8.6% |
| Cash & Short-Term Equivalents | $820.3M | $2.14B | — |
| Total Debt (Short + Long Term) | $12.65B | $11.97B | $1.58B |
| Total Stockholders' Equity | $6.36B | $6.09B | $3.25B |